Cargando…
Arginine deiminase: a potential inhibitor of angiogenesis and tumour growth
Hydrolysis of plasma arginine to citrulline by arginine deiminase (ADI) was recently shown to suppress lipopolysaccharide-induced nitric oxide (NO) synthesis. Since arginine is the precursor of NO, and the latter modulates angiogenesis, we explored whether ADI treatment significantly affected tube-l...
Autores principales: | Park, I-S, Kang, S-W, Shin, Y-J, Chae, K-Y, Park, M-O, Kim, M-Y, Wheatley, D N, Min, B-H |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394481/ https://www.ncbi.nlm.nih.gov/pubmed/12942125 http://dx.doi.org/10.1038/sj.bjc.6601181 |
Ejemplares similares
-
Arginine deprivation, growth inhibition and tumour cell death: 2. Enzymatic degradation of arginine in normal and malignant cell cultures
por: Philip, R, et al.
Publicado: (2003) -
Arginine deprivation, growth inhibition and tumour cell death: 3. Deficient utilisation of citrulline by malignant cells
por: Wheatley, D N, et al.
Publicado: (2003) -
Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase
por: Feun, L G, et al.
Publicado: (2012) -
Overexpression of the p53-inducible brain-specific angiogenesis inhibitor 1 suppresses efficiently tumour angiogenesis
por: Duda, D G, et al.
Publicado: (2002) -
Arginine deiminase PEG20 inhibits growth of small cell lung cancers lacking expression of argininosuccinate synthetase
por: Kelly, M P, et al.
Publicado: (2012)